William Blair Investment Management LLC Has $107.11 Million Stake in Inspire Medical Systems, Inc. $INSP

William Blair Investment Management LLC decreased its holdings in shares of Inspire Medical Systems, Inc. (NYSE:INSP) by 10.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,161,285 shares of the company’s stock after selling 136,288 shares during the quarter. William Blair Investment Management LLC’s holdings in Inspire Medical Systems were worth $107,105,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in the business. Xponance Inc. boosted its holdings in Inspire Medical Systems by 2.9% during the third quarter. Xponance Inc. now owns 4,177 shares of the company’s stock worth $310,000 after purchasing an additional 116 shares during the last quarter. Daiwa Securities Group Inc. boosted its holdings in Inspire Medical Systems by 38.7% during the second quarter. Daiwa Securities Group Inc. now owns 466 shares of the company’s stock worth $60,000 after purchasing an additional 130 shares during the last quarter. Blair William & Co. IL boosted its holdings in Inspire Medical Systems by 5.1% during the third quarter. Blair William & Co. IL now owns 4,865 shares of the company’s stock worth $361,000 after purchasing an additional 234 shares during the last quarter. CWM LLC boosted its holdings in Inspire Medical Systems by 216.1% during the fourth quarter. CWM LLC now owns 354 shares of the company’s stock worth $33,000 after purchasing an additional 242 shares during the last quarter. Finally, XTX Topco Ltd boosted its holdings in Inspire Medical Systems by 4.3% during the third quarter. XTX Topco Ltd now owns 7,289 shares of the company’s stock worth $541,000 after purchasing an additional 300 shares during the last quarter. Institutional investors and hedge funds own 94.91% of the company’s stock.

Inspire Medical Systems Price Performance

Shares of INSP stock opened at $43.79 on Friday. The stock has a market cap of $1.26 billion, a P/E ratio of 9.75, a P/E/G ratio of 4.53 and a beta of 0.83. The company has a fifty day moving average price of $51.61 and a two-hundred day moving average price of $76.29. Inspire Medical Systems, Inc. has a one year low of $39.61 and a one year high of $147.66.

Inspire Medical Systems (NYSE:INSP) last announced its quarterly earnings results on Monday, May 4th. The company reported $0.10 EPS for the quarter, beating analysts’ consensus estimates of ($0.28) by $0.38. The firm had revenue of $204.58 million during the quarter, compared to analysts’ expectations of $200.04 million. Inspire Medical Systems had a net margin of 14.33% and a return on equity of 10.35%. The company’s revenue for the quarter was up 1.6% compared to the same quarter last year. During the same quarter last year, the company posted $0.10 earnings per share. Inspire Medical Systems has set its FY 2026 guidance at 0.750-1.250 EPS. As a group, equities research analysts anticipate that Inspire Medical Systems, Inc. will post 0.91 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts recently commented on the stock. Wolfe Research cut shares of Inspire Medical Systems from an “outperform” rating to a “peer perform” rating in a report on Friday, February 13th. Wells Fargo & Company reduced their target price on shares of Inspire Medical Systems from $70.00 to $56.00 and set an “equal weight” rating for the company in a report on Tuesday, May 5th. Morgan Stanley set a $60.00 target price on shares of Inspire Medical Systems in a report on Wednesday, February 18th. JPMorgan Chase & Co. reduced their target price on shares of Inspire Medical Systems from $67.00 to $54.00 and set a “neutral” rating for the company in a report on Tuesday, May 5th. Finally, Weiss Ratings cut shares of Inspire Medical Systems from a “sell (d+)” rating to a “sell (d)” rating in a report on Wednesday, May 6th. Four analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average price target of $81.84.

About Inspire Medical Systems

Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company’s flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.